112 related articles for article (PubMed ID: 11364367)
1. Clinical trials and viral load: statement for FDA community meeting May 16. Food and Drug Administration.
James JS
AIDS Treat News; 1997 May; (No 271):1-4. PubMed ID: 11364367
[TBL] [Abstract][Full Text] [Related]
2. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
AIDS Treat News; 1997 May; (No 270):3. PubMed ID: 11364324
[TBL] [Abstract][Full Text] [Related]
3. AIDS researchers seek criteria for vaccines.
Check E
Nature; 2003 May; 423(6936):107. PubMed ID: 12736647
[No Abstract] [Full Text] [Related]
4. FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James.
Feigal D
AIDS Treat News; 1997 Jun; (No 273):1-5. PubMed ID: 11364399
[TBL] [Abstract][Full Text] [Related]
5. Therapies. Confronting the limits of success.
Cohen J
Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
[No Abstract] [Full Text] [Related]
6. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
8. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
9. FDA evaluates accelerated approval process. Food and Drug Administration.
Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy in HIV/AIDS: update from San Francisco.
Laurence J
AIDS Read; 2000 Mar; 10(3):133-4. PubMed ID: 10758008
[No Abstract] [Full Text] [Related]
11. Viral load: inconclusive FDA hearing. Food and Drug Administration.
James JS
AIDS Treat News; 1996 Apr; (no 244):5. PubMed ID: 11363306
[TBL] [Abstract][Full Text] [Related]
12. FDA workshop on clinical trial design, September 6-7--registration by Aug. 18. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Aug; (no 228):5-6. PubMed ID: 11362627
[TBL] [Abstract][Full Text] [Related]
13. AIDS task force grapples with faster access to protease drugs.
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Mar; 1(2):6-11. PubMed ID: 11362314
[TBL] [Abstract][Full Text] [Related]
14. FDA Advisory Committee stalemates on delavirdine.
AIDS Patient Care STDS; 1997 Apr; 11(2):96-7. PubMed ID: 11361773
[No Abstract] [Full Text] [Related]
15. FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration.
AIDS Treat News; 1999 Nov; (No 331):5-6. PubMed ID: 11367127
[TBL] [Abstract][Full Text] [Related]
16. On approval.
Huff B
GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
[No Abstract] [Full Text] [Related]
17. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
18. HIV therapeutics, continued: another HIV protease inhibitor approved.
Laurence J
AIDS Read; 2003 Aug; 13(8):355-6. PubMed ID: 14524318
[No Abstract] [Full Text] [Related]
19. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
20. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
